Company news

Organogenesis Holdings Inc. news in 2021

Organogenesis Holdings Inc.'s news releases, calls and decks from 2021, newest first.

View company

Organogenesis Appoints Prathyusha Duraibabu to Board of Directors

November 21, 2021

Organogenesis Holdings Inc. Reports Third Quarter and First Nine Months 2021 Financial Results

November 8, 2021

Organogenesis Holdings Inc. to Participate in the Credit Suisse 30th Annual Healthcare Conference

November 7, 2021

Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Fall 2021 Conference

October 26, 2021

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2021 Financial Results on November 9, 2021

October 6, 2021

Organogenesis Holdings Inc. Reports Second Quarter and First Half 2021 Financial Results

August 8, 2021

Organogenesis Holdings Inc. Announces New $200 Million Credit Agreement with Silicon Valley Bank

August 8, 2021

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2021 Financial Results on August 9, 2021

July 1, 2021

Organogenesis Holdings Inc. Reports First Quarter 2021 Financial Results

May 9, 2021

Organogenesis Appoints Jon Giacomin to Board of Directors

May 9, 2021

CORRECTING and REPLACING – Organogenesis Holdings Inc. Reports First Quarter 2021 Financial Results

May 9, 2021

Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Spring | WHS 2021 Virtual Meeting

May 5, 2021

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2021 Financial Results on May 10, 2021

April 11, 2021

Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2020 Financial Results; Introduces Fiscal Year 2021 Guidance

March 15, 2021

Organogenesis Appoints David C. Francisco as Chief Financial Officer

February 15, 2021

Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in February and March

February 8, 2021

Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2020 Financial Results on March 16, 2021

February 7, 2021

Organogenesis Enrolls First Patient in Pivotal Phase 3 Clinical Trial of RMAT-Designated ReNu® for Knee Osteoarthritis

January 13, 2021

Organogenesis Holdings Inc. Reports Preliminary Financial Results for Fourth Quarter and Fiscal Year 2020

January 12, 2021

Organogenesis ReNu® Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation For Osteoarthritis of the Knee

January 10, 2021

Organogenesis Holdings Inc. to Participate in the ICR Conference 2021

January 4, 2021

Calls in 2021